{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T00:51:53Z","timestamp":1790297513863,"version":"4.1.0"},"reference-count":19,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,26]],"date-time":"2022-07-26T00:00:00Z","timestamp":1658793600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Public Health"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.jiph.2022.07.012","type":"journal-article","created":{"date-parts":[[2022,7,28]],"date-time":"2022-07-28T12:47:12Z","timestamp":1659012432000},"page":"955-960","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Changes in the user profiles of HIV pre-exposure prophylaxis (PrEP) before and after PrEP reimbursement"],"prefix":"10.1016","volume":"15","author":[{"given":"Patrick","family":"Ahaus","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Axel J.","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriane","family":"Skaletz-Rorowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mona","family":"Uhrmacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katja","family":"Serova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arne","family":"Kayser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janet","family":"Wach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandeep","family":"Nambiar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norbert H.","family":"Brockmeyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anja","family":"Potthoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jiph.2022.07.012_bib1","unstructured":"Stellbrink Hans-J.\u00fcrgen, Brockmeyer N.H., Esser S., et al. Deutsch-\u00d6sterreichische Leitlinien zur HIV-Pr\u00e4expositionsprophylaxe; 2018. Available from: URL: \u3008https:\/\/daignet.de\/site-content\/hiv-therapie\/leitlinien-1\/deutsch-oesterreichische-leitlinien-zur-hiv-praeexpositionsprophylaxe\u3009."},{"key":"10.1016\/j.jiph.2022.07.012_bib2","unstructured":"Brockmeyer N., Coenenberg J., Esser S., et al. Positionen und Empfehlungen zur HIV-Pr\u00e4expositionsprophylaxe (PrEP) der Deutschen STI-Gesellschaft (DSTIG) 2017."},{"key":"10.1016\/j.jiph.2022.07.012_bib3","doi-asserted-by":"crossref","first-page":"799","DOI":"10.3389\/fphar.2018.00799","article-title":"Efficacy and safety of oral TDF-based pre-exposure prophylaxis for men who have sex with men: a systematic review and meta-analysis","volume":"9","author":"Huang","year":"2018","journal-title":"Front Pharm"},{"issue":"9","key":"10.1016\/j.jiph.2022.07.012_bib4","doi-asserted-by":"crossref","first-page":"e402","DOI":"10.1016\/S2352-3018(17)30089-9","article-title":"Efficacy, safety, and effect on sexual behaviour of on-demand pre-exposure prophylaxis for HIV in men who have sex with men: an observational cohort study","volume":"4","author":"Molina","year":"2017","journal-title":"Lancet HIV"},{"issue":"10013","key":"10.1016\/j.jiph.2022.07.012_bib5","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0140-6736(15)00056-2","article-title":"Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial","volume":"387","author":"McCormack","year":"2016","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.jiph.2022.07.012_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/hiv.12528","article-title":"InterPrEP: internet-based pre-exposure prophylaxis with generic tenofovir disoproxil fumarate\/emtrictabine in London - analysis of pharmacokinetics, safety and outcomes","volume":"19","author":"Wang","year":"2018","journal-title":"HIV Med"},{"issue":"4","key":"10.1016\/j.jiph.2022.07.012_bib7","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/s13178-019-00413-0","article-title":"European men-who-have-sex-with-men internet survey (EMIS-2017): design and methods","volume":"17","author":"Weatherburn","year":"2020","journal-title":"Sex Res Soc Policy"},{"issue":"10","key":"10.1016\/j.jiph.2022.07.012_bib8","doi-asserted-by":"crossref","DOI":"10.1002\/jia2.25395","article-title":"Factors associated with the informal use of HIV pre-exposure prophylaxis in Germany: a cross-sectional study","volume":"22","author":"Koppe","year":"2019","journal-title":"J Int AIDS Soc"},{"key":"10.1016\/j.jiph.2022.07.012_bib9","unstructured":"Schu M., Enders K., Tossmann P., et al. \u201cAbschlussbericht der wissenschaftlichen Begleitung des Zentrums f\u00fcr Sexuelle Gesundheit und Medizin,\u201cWalk In Ruhr\u201d in Bochum, 2020."},{"issue":"3","key":"10.1016\/j.jiph.2022.07.012_bib10","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s15010-018-1127-3","article-title":"2016 PREP attitudes in Germany: high awareness and acceptance in MSM at risk of HIV","volume":"46","author":"Spinner","year":"2018","journal-title":"Infection"},{"issue":"2","key":"10.1016\/j.jiph.2022.07.012_bib11","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1097\/QAI.0000000000001791","article-title":"Choosing between daily and event-driven pre-exposure prophylaxis: results of a Belgian PrEP demonstration project","volume":"79","author":"Reyniers","year":"2018","journal-title":"JAIDS J Acquir Immune Defic Syndr"},{"issue":"2","key":"10.1016\/j.jiph.2022.07.012_bib12","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1089\/apc.2011.0283","article-title":"Sexual risk behaviors and acceptability of HIV pre-exposure prophylaxis among HIV-negative gay and bisexual men in serodiscordant relationships: a mixed methods study","volume":"26","author":"Brooks","year":"2012","journal-title":"AIDS Patient Care STDS"},{"key":"10.1016\/j.jiph.2022.07.012_bib13","article-title":"Increases in pre-exposure prophylaxis use and decreases in condom use: behavioral patterns among hiv-negative San Francisco men who have sex with men, 2004-2017","author":"Chen","year":"2018","journal-title":"AIDS Behav"},{"issue":"4","key":"10.1016\/j.jiph.2022.07.012_bib14","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1136\/sextrans-2011-050312","article-title":"Willingness to use HIV pre-exposure prophylaxis and the likelihood of decreased condom use are both associated with unprotected anal intercourse and the perceived likelihood of becoming HIV positive among Australian gay and bisexual men","volume":"88","author":"Holt","year":"2012","journal-title":"Sex Transm Infect"},{"key":"10.1016\/j.jiph.2022.07.012_bib15","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.drugpo.2016.09.007","article-title":"Illicit drug use among gay and bisexual men in 44 cities: Findings from the European MSM Internet Survey (EMIS)","volume":"38","author":"Schmidt","year":"2016","journal-title":"Int J Drug Policy"},{"issue":"14","key":"10.1016\/j.jiph.2022.07.012_bib16","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1001\/jama.2019.2947","article-title":"Association of HIV preexposure prophylaxis with incidence of sexually transmitted infections among individuals at high risk of HIV infection","volume":"321","author":"Traeger","year":"2019","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.jiph.2022.07.012_bib17","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1097\/QAD.0000000000001718","article-title":"Incidence of sexually transmitted infections before and after preexposure prophylaxis for HIV","volume":"32","author":"Nguyen","year":"2018","journal-title":"AIDS"},{"issue":"1","key":"10.1016\/j.jiph.2022.07.012_bib18","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/s12879-020-4831-4","article-title":"STI in times of PrEP: high prevalence of chlamydia, gonorrhea, and mycoplasma at different anatomic sites in men who have sex with men in Germany","volume":"20","author":"Jansen","year":"2020","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.jiph.2022.07.012_bib19","author":"Schmidt","year":"2020","journal-title":"The Swiss STAR trial \u2014 an evaluation of target groups for sexually transmitted infection screening in the sub-sample of me"}],"container-title":["Journal of Infection and Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876034122001915?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876034122001915?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T15:16:11Z","timestamp":1761750971000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1876034122001915"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":19,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["S1876034122001915"],"URL":"https:\/\/doi.org\/10.1016\/j.jiph.2022.07.012","relation":{},"ISSN":["1876-0341"],"issn-type":[{"value":"1876-0341","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Changes in the user profiles of HIV pre-exposure prophylaxis (PrEP) before and after PrEP reimbursement","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Public Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiph.2022.07.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Ltd on behalf of King Saud Bin Abdulaziz University for Health Sciences.","name":"copyright","label":"Copyright"}]}}